Aerobic exercise inhibits obesity-induced respiratory phenotype
Carregando...
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
Autores
AQUINO-JUNIOR, Jefferson Comin Jonco
MACKENZIE, BreAnne
ALMEIDA-OLIVEIRA, Ana Roberta
MARTINS, Ana Carolina
OLIVEIRA-JUNIOR, Manoel Carneiro
BRITTO, Aurilea Aparecida
OLIVEIRA, Ana Paula Ligeiro de
Citação
CYTOKINE, v.104, p.46-52, 2018
Resumo
Purpose: Obesity results in decreased lung function and increased inflammation. Moderate aerobic exercise (AE) reduced lung inflammation and remodeling in a variety of respiratory disease models. Therefore, this study investigated whether AE can attenuate a diet-induced obesity respiratory phenotype; including airway hyperresponsiveness (AHR), remodeling and inflammation.& para;& para;Methods: Sixty C57B1/6 male mice were distributed into four groups: control lean (CL), exercise lean (EL), obese (O) and obese exercise (OE) groups (2 sets of 7 and 8 mice per group; n = 15). A classical model of diet-induced obesity (DIO) over 12 weeks was used. AE was performed 60 min/day, 5 days/week for 5 weeks. Airway hyperresponsiveness (AHR), lung inflammation and remodeling, adipokines and cytokines in bronchoalveolar lavage (BAL) was determined.& para;& para;Results: A high fat diet over 18 weeks significantly increased body weight (p < .0001). Five weeks of AE significantly reduced both AHR and pulmonary inflammation. AHR in obese mice that exercised was reduced at the basal level (p < .05), vehicle (PBS) (p < .05), 6.25 MCh mg/mL (p < .05), 12.5 MCh mg/mL (p < .01), 25 MCh mg/mL (p < .01) and 50 MCh mg/mL (p < .05). Collagen (p < .001) and elastic (p < .001) fiber deposition in airway wall and also smooth muscle thickness (p < .001) were reduced. The number of neutrophils (p < .001), macrophages (p < .001) and lymphocytes (p < .01) were reduced in the peribronchial space as well as in the BAL: lymphocytes (p < .01), macrophages (p < .01), neutrophils (p < .001). AE reduced obesity markers leptin (p < .001), IGF-1 (p < .01) and VEGF (p < .001), while increased adiponectin (p < .01) in BAL. AE also reduced pro-inflammatory cytokines in the SAL: IL-1 beta (p < .001), IL-12p40 (p < .001), IL-13 (p < .01), IL-17 (p < .001, IL-23 (p < .05) and TNF-alpha (p < .05), and increased antiinflammatory cytokine IL-10 (p < .05).& para;& para;Conclusions: Aerobic exercise reduces high fat diet-induced obese lung phenotype (AHR, pulmonary remodeling and inflammation), involving anti-inflammatory cytokine IL-10 and adiponectin.
Palavras-chave
Obesity, Hyperresponsiveness, Lung inflammation, Asthma, Exercise immunology, Adipokines
Referências
- Baffi C.W., 2015, ASTHMA RES PRACT, V1, P11
- Baruwa Pranab, 2013, Lung India, V30, P38, DOI 10.4103/0970-2113.106132
- de V.F. Andrade, 2008, AM J PHYSIOL-LUNG C, V295, pL670
- Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437
- Freitas PD, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0111-2
- Jensen ME, 2013, CLIN EXP ALLERGY, V43, P775, DOI 10.1111/cea.12115
- Johnston R.A., 2008, J APPL PHYSIOL, V104
- Johnston RA, 2007, AM J RESP CRIT CARE, V176, P650, DOI 10.1164/rccm.200702-323OC
- Kankaanranta H, 2016, MEDIAT INFLAMM, DOI 10.1155/2016/3690628
- Kobayashi K, 2000, METABOLISM, V49, P22, DOI 10.1016/S0026-0495(00)90588-2
- Li C, 2007, OBESITY, V15, P216, DOI 10.1038/oby.2007.505
- de Oliveira APL, 2007, AM J PHYSIOL-CELL PH, V293, pC1120, DOI 10.1152/ajpcell.00286.2006
- Littleton SW, 2012, RESPIROLOGY, V17, P43, DOI 10.1111/j.1440-1843.2011.02096.x
- McClean KM, 2008, THORAX, V63, P649, DOI 10.1136/thx.2007.086801
- Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
- Naik D, 2014, INDIAN J ENDOCRINOL, V18, P608, DOI [DOI 10.4103/2230-8210.139212, 10.4103/2230-8210.139212]
- Reddel H.K., 2015, EUR RESP J
- Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004
- Silva RA, 2010, EUR RESPIR J, V35, P994, DOI 10.1183/09031936.00049509
- Toledo AC, 2012, EUR RESPIR J, V39, P254, DOI 10.1183/09031936.00003411
- Vernooy JHJ, 2013, PULM PHARMACOL THER, V26, P464, DOI 10.1016/j.pupt.2013.03.016
- Vieira RP, 2007, AM J RESP CRIT CARE, V176, P871, DOI 10.1164/rccm.200610-1567OC
- Vieira RP, 2011, RESP PHYSIOL NEUROBI, V175, P383, DOI 10.1016/j.resp.2011.01.002
- Williams AS, 2015, AM J PHYSIOL-LUNG C, V308, pL1168, DOI 10.1152/ajplung.00393.2014
- World Health Organization, 2016, OB OV WHO
- Zammit C, 2010, INT J GEN MED, V3, P335, DOI 10.2147/IJGM.S11926